CVS icon

CVS Health

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 32.3%
Negative

Positive
Zacks Investment Research
2 days ago
Why Is CVS Health (CVS) Up 4.1% Since Last Earnings Report?
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock?
Why Is CVS Health (CVS) Up 4.1% Since Last Earnings Report?
Positive
Zacks Investment Research
2 days ago
CVS Health Delivers MBR Improvement: Is More Progress in the Cards?
CVS posts a sharper MBR as PDR impacts ease and government business strengthens while maintaining a cautious full-year outlook.
CVS Health Delivers MBR Improvement: Is More Progress in the Cards?
Positive
Invezz
3 days ago
These outperforming stocks are still cheap heading into 2026
US stocks have been in a sharp uptrend over the past seven months, with the benchmark S&P 500 index currently up more than 35% versus its year-to-date low in April. Still, a handful of outperformers are trading at relatively low forward valuations heading into 2026.
These outperforming stocks are still cheap heading into 2026
Positive
Zacks Investment Research
4 days ago
Battle of Benefits: Will UNH Deliver the Bigger Dose or CVS? (Revised)
CVS's rising margins, stronger guidance and sharper valuation edge make it stand out in the UNH vs. CVS upside debate.
Battle of Benefits: Will UNH Deliver the Bigger Dose or CVS? (Revised)
Positive
Zacks Investment Research
4 days ago
Battle of Benefits: Will UNH Deliver the Bigger Dose or CVH?
CVS's rising margins, stronger guidance and sharper valuation edge make it stand out in the UNH vs. CVS upside debate.
Battle of Benefits: Will UNH Deliver the Bigger Dose or CVH?
Positive
Zacks Investment Research
5 days ago
CVS vs. WMT: Which Retail Pharmacy Powerhouse Looks Stronger Now?
CVS gains momentum with record revenues, stronger guidance and a cheaper valuation, standing out in the retail pharmacy comparison with WMT.
CVS vs. WMT: Which Retail Pharmacy Powerhouse Looks Stronger Now?
Negative
CNBC
5 days ago
Abortion pill makers brace for restrictions a year after Trump's election
Federal rules on the abortion pill mifepristone remain unchanged a year after President Donald Trump's election, but an FDA safety review has stirred new uncertainty. State enforcement and lawsuits are reshaping access and liability across a $6.9 billion abortion drugs market in the U.S., which is reliant on telehealth and mail delivery.
Abortion pill makers brace for restrictions a year after Trump's election
Neutral
GlobeNewsWire
6 days ago
Curaechoice Selects CVS Caremark at its PBM
All Active Curaechoice Members and their Families Will Have Access to CVS Pharmacies Nationwide Starting January 1 All Active Curaechoice Members and their Families Will Have Access to CVS Pharmacies Nationwide Starting January 1
Curaechoice Selects CVS Caremark at its PBM
Positive
Seeking Alpha
6 days ago
Wall Street Breakfast Podcast: Ubisoft Cracks Next Level With Tencent
Ubisoft Entertainment (OTCPK:UBSFY) surged nearly 9% after Tencent invested €1.16B in its Vantage Studios, boosting transformation and reducing debt. Tencent (OTCPK:TCEHY) now holds a 26.32% economic interest in Vantage Studios, while Ubisoft retains exclusive control and consolidation.
Wall Street Breakfast Podcast: Ubisoft Cracks Next Level With Tencent
Neutral
PRNewsWire
10 days ago
CVS Health Names David Joyner Chair of the Board of Directors
WOONSOCKET, R.I. , Nov. 20, 2025 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced that its Board of Directors has elected President and Chief Executive Officer David Joyner as Chair of the Board, effective January 1, 2026.
CVS Health Names David Joyner Chair of the Board of Directors